- Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant. Chen, Q., Jackson, H., Parente, P., Luke, T., Rizkalla, M., Tai, T.Y., Zhu, H.C., Mifsud, N.A., Dimopoulos, N., Masterman, K.A., Hopkins, W., Goldie, H., Maraskovsky, E., Green, S., Miloradovic, L., McCluskey, J., Old, L.J., Davis, I.D., Cebon, J., Chen, W. Proc. Natl. Acad. Sci. U.S.A. (2004)









